Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Wingard

Showing results (191-200 of 267) with videos related to

Pageof 27
Sort By:
Cancer|October 7, 2015
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)William A Wood, Jennifer Le-Rademacher, Karen L Syrjala, et al.
Journal of Clinical Microbiology|April 11, 2014
Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United StatesPaschalis Vergidis, Raymund R Razonable, L Joseph Wheat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2014
Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902Paul B Jacobsen, Jennifer Le-Rademacher, Heather Jim, et al.
Medical Mycology|April 25, 2015
Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)Todd P McCarty, John W Baddley, Thomas J Walsh, et al.
Transplantation and Cellular Therapy|April 18, 2021
The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 PandemicJack W Hsu, Nosha Farhadfar, Hemant Murthy, et al.
Open Forum Infectious Diseases|October 11, 2021
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?John R Wingard, Barbara D Alexander, Lindsey R Baden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocolGregory A Yanik, Mary M Horowitz, Daniel J Weisdorf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2010
Factors associated with mortality in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2016
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 TrialJennifer M Knight, Karen L Syrjala, Navneet S Majhail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2025
Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute LeukemiaJohn R Wingard, Ji-Hyun Lee, Derek Li, et al.
Pageof 27

Showing results (191-200 of 267) with videos related to

Sort By:
Pageof 27
Cancer|October 7, 2015
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)William A Wood, Jennifer Le-Rademacher, Karen L Syrjala, et al.
Journal of Clinical Microbiology|April 11, 2014
Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United StatesPaschalis Vergidis, Raymund R Razonable, L Joseph Wheat, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2014
Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902Paul B Jacobsen, Jennifer Le-Rademacher, Heather Jim, et al.
Medical Mycology|April 25, 2015
Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET)Todd P McCarty, John W Baddley, Thomas J Walsh, et al.
Transplantation and Cellular Therapy|April 18, 2021
The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 PandemicJack W Hsu, Nosha Farhadfar, Hemant Murthy, et al.
Open Forum Infectious Diseases|October 11, 2021
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?John R Wingard, Barbara D Alexander, Lindsey R Baden, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocolGregory A Yanik, Mary M Horowitz, Daniel J Weisdorf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2010
Factors associated with mortality in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 28, 2016
Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 TrialJennifer M Knight, Karen L Syrjala, Navneet S Majhail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2025
Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute LeukemiaJohn R Wingard, Ji-Hyun Lee, Derek Li, et al.
Pageof 27